Bempedoic acid,ezetimibe,evolocumab,alirocumab
amgen,regeneron,esperion
[]
 . absolute risk reduction is related to absolute baseline risk and absolute ldl-c-lowering. it is a false equivalence to compare these trials, or to draw comparative conclusions about ba vs pcsk9i.
Cardiometabolic medicine. Endocrinology, lipidology, obesity medicine. Via @PennMedicine and @MGHMedicine.